Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose

COVID-19 disease has infected millions of people worldwide during the pandemic; hence, the need for an effective and safe vaccine was urgently required. A two-dose of the BNT162b2 mRNA COVID-19 vaccine was reported to have 95% efficacy in preventing COVID-19. The short-term safety profile recorded m...

Descripción completa

Detalles Bibliográficos
Autores principales: Miqdad, Mohammed A, Nasser, Hamze, Alshehri, Abdullah, Mourad, Abdul Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599115/
https://www.ncbi.nlm.nih.gov/pubmed/34804729
http://dx.doi.org/10.7759/cureus.18880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599115/
https://www.ncbi.nlm.nih.gov/pubmed/34804729
http://dx.doi.org/10.7759/cureus.18880

Ejemplares similares